Daito Pharmaceutical Co.,Ltd. (TYO:4577)
1,348.00
+4.00 (0.30%)
Jan 21, 2026, 3:30 PM JST
Daito Pharmaceutical Company Description
Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally.
It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs.
The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries.
The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992.
Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.
Daito Pharmaceutical Co.,Ltd.
| Country | Japan |
| Founded | 1942 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,073 |
| CEO | Hiroshi Matsumori |
Contact Details
Address: 326 Yokamachi Toyama, 939-8567 Japan | |
| Phone | 81 7 6421 5665 |
| Website | daitonet.co.jp |
Stock Details
| Ticker Symbol | 4577 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | June - May |
| Reporting Currency | JPY |
| ISIN Number | JP3486150000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hiroshi Matsumori | Chief Executive Officer |
| Kenji Otsuga | Chief Financial Officer |